Clinical trial
Improving Oral Hormonal Therapy Adherence in Breast Cancer Survivors by Using eHealth as a New Intervention Tool
NCT05324020 is registered in ClinicalTrials.gov with Luxembourg Institute of Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving Oral Hormonal Therapy Adherence in Breast Cancer Survivors by Using eHealth as a New Intervention Tool
- Lead sponsor
- Luxembourg Institute of Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 4, 2021
- Completion date
- November 30, 2022
- Enrollment
- 3 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer